Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A considerable proportion of those diagnosed with the potentially blinding STI in North Carolina are simultaneously diagnosed with HIV.
Previous research on bone loss during the first year on PrEP may have failed to consider poor adherence to the regimen.
Poorer countries also show a discrepancy between the life spans of men and women beginning antiretrovirals.
Such diseases include Sjögren’s syndrome, psoriasis and systemic lupus erythematous.
The CDC’s first state-by state breakdown of rates of the STI among men who have sex with men reveals a heavy burden in the South.
Despite the expansion of HIV treatment, rates of end-stage liver disease among those coinfected with hepatitis B or C remain unchanged.
The last line of defense against the STI is weakening; however, an experimental treatment showed promise in a recent Phase II trial.
After losing bone density during a year on PrEP, young men recouped their losses a year later but didn’t catch up with norms.
Despite all the excited talk of ending the epidemic, annual global HIV infection rates have not declined for a decade.
A program offering cash for behavior change did not improve viral suppression rates among this population.
Students often report they are provided with out-of-touch, moralizing, sex-negative and heterosexist sexual education in school.
The vast majority of the group surveyed was aware of the HIV prevention method, with one in 10 in reporting having used it as of a year ago.
The advocacy group recognizes leadership under the AIDS Drug Assistance Program (ADAP).
Scientists succeed with new methods of spurring the immune system to manufacture broadly neutralizing antibodies against the virus.
Only those who began with a normal BMI had the increased risk of heart disease, however.
Hospitalization for anxiety and mood disorders also linked to increased risk of death.